AVXL logo

Anavex Life Sciences (AVXL) Selling, General & Administrative Expenses

Annual SGA

$11.04 M
-$1.00 M-8.31%

September 30, 2024

Summary

Performance

1-Year Change

-8.31%

3-Year Change

+22.41%

5-Year Change

+61.23%

15-Year Change

+120.41%

AVXL SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.62%
AVXL annual SGA is higher than 24.62% of companies in Healthcare sector

High & Low

All-time High

$13.07 M
AVXL annual SGA is currently -15.54% below its historical high of $13.07 million

3-Year Low

$9.02 M
AVXL annual SGA is currently +22.41% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
AVXL previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
AVXL next annual earnings announcement has not yet been scheduled

OtherAVXLexpensesmetrics:

Annual Total Expenses

$52.80 M
AVXL annual total expenses is $52.80 million

Annual Operating Expenses

$52.80 M
AVXL annual total operating expenses is $52.80 million

Annual Cost Of Goods Sold

-
AVXL annual cost of goods sold value is unknown

Annual Interest Expense

$0.00
AVXL annual interest expense is $0.00

Quarterly SGA

$3.15 M
+$365.00 K+13.12%

December 31, 2024

Summary

Performance

3-Month Change

+13.12%

1-Year Change

+13.12%

3-Year Change

+13.12%

5-Year Change

+13.12%

AVXL Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.37%
AVXL quarterly SGA is higher than 27.37% of companies in Healthcare sector

High & Low

All-time High

$3.90 M
AVXL quarterly SGA is currently -19.38% below its historical high of $3.90 million

3-Year Low

$2.59 M
AVXL quarterly SGA is currently +21.37% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
AVXL previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
AVXL next earnings announcement is scheduled for May 9, 2025

OtherAVXLexpensesmetrics:

Quarterly Total Expenses

$13.58 M
AVXL quarterly total expenses is $13.58 million

Quarterly Operating Expenses

$13.58 M
AVXL quarterly total operating expenses is $13.58 million

Quarterly Cost Of Goods Sold

-
AVXL quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
AVXL quarterly interest expense value is unknown

TTM SGA

-$1.32 B
-$46.49 M-3.65%

December 31, 2024

Summary

Performance

3-Month Change

-11974.69%

1-Year Change

-11974.69%

3-Year Change

-11974.69%

5-Year Change

-11974.69%

AVXL TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.05%
AVXL TTM SGA is higher than 38.05% of companies in Healthcare sector

High & Low

All-time High

-$106.00 K

3-Year Low

-$1.32 B
AVXL TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
AVXL previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
AVXL next earnings announcement is scheduled for May 9, 2025

OtherAVXLexpensesmetrics:

Annual Total Expenses

$52.80 M
AVXL annual total expenses is $52.80 million

Annual Operating Expenses

$52.80 M
AVXL annual total operating expenses is $52.80 million

TTM Cost Of Goods Sold

-
AVXL TTM cost of goods sold value is unknown

TTM Interest Expense

-
AVXL TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$11.04 M
AVXL annual SGA is $11.04 million

Annual Operating Expenses

$52.80 M
AVXL annual total operating expenses is $52.80 million

Annual Cost Of Goods Sold

-
AVXL annual cost of goods sold value is unknown

AVXL Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.3%+13.1%-10000.0%
3 y3 years+22.4%+13.1%-10000.0%
5 y5 years+61.2%+13.1%-10000.0%

AVXL Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-15.5%+22.4%-19.4%+21.4%-72.1%at low
5 y5-year-15.5%+88.5%-19.4%+132.7%-149.7%at low
alltimeall time-15.5%-100.0%-19.4%-100.0%<-9999.0%at low

Anavex Life Sciences Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
-
$3.15 M(+13.1%)
$11.58 M(+4.1%)
Sep 2024
$11.04 M(-8.3%)
$2.78 M(-2.7%)
$11.12 M(+1.7%)
Jun 2024
-
$2.86 M(+2.5%)
$10.94 M(-3.4%)
Mar 2024
-
$2.79 M(+3.6%)
$11.32 M(-0.8%)
Dec 2023
-
$2.69 M(+3.9%)
$11.42 M(-5.2%)
Sep 2023
$12.04 M(-7.9%)
$2.59 M(-20.2%)
$12.04 M(-9.8%)
Jun 2023
-
$3.25 M(+12.7%)
$13.35 M(+0.5%)
Mar 2023
-
$2.88 M(-13.1%)
$13.29 M(-0.2%)
Dec 2022
-
$3.32 M(-15.0%)
$13.32 M(+1.9%)
Sep 2022
$13.07 M(+44.9%)
$3.90 M(+22.5%)
$13.07 M(+8.5%)
Jun 2022
-
$3.19 M(+9.3%)
$12.05 M(+6.7%)
Mar 2022
-
$2.92 M(-4.9%)
$11.30 M(+6.4%)
Dec 2021
-
$3.07 M(+6.5%)
$10.61 M(+17.7%)
Sep 2021
$9.02 M(+54.0%)
$2.88 M(+18.3%)
$9.02 M(+19.6%)
Jun 2021
-
$2.43 M(+9.0%)
$7.54 M(+16.2%)
Mar 2021
-
$2.23 M(+51.9%)
$6.49 M(+8.6%)
Dec 2020
-
$1.47 M(+4.8%)
$5.98 M(+2.0%)
Sep 2020
$5.86 M(-14.5%)
$1.40 M(+1.6%)
$5.86 M(-3.8%)
Jun 2020
-
$1.38 M(-19.7%)
$6.09 M(-0.1%)
Mar 2020
-
$1.72 M(+27.2%)
$6.10 M(-5.3%)
Dec 2019
-
$1.35 M(-17.3%)
$6.44 M(-6.0%)
Sep 2019
$6.85 M(+14.3%)
$1.64 M(+17.8%)
$6.85 M(+2.3%)
Jun 2019
-
$1.39 M(-32.6%)
$6.69 M(-3.3%)
Mar 2019
-
$2.06 M(+17.0%)
$6.92 M(+9.0%)
Dec 2018
-
$1.76 M(+18.9%)
$6.35 M(+6.1%)
Sep 2018
$5.99 M(+19.6%)
$1.48 M(-8.6%)
$5.99 M(+2.1%)
Jun 2018
-
$1.62 M(+8.8%)
$5.87 M(+3.8%)
Mar 2018
-
$1.49 M(+6.6%)
$5.65 M(+7.1%)
Dec 2017
-
$1.40 M(+2.7%)
$5.28 M(+5.4%)
Sep 2017
$5.01 M(-39.9%)
$1.36 M(-3.1%)
$5.01 M(-27.0%)
Jun 2017
-
$1.41 M(+25.9%)
$6.86 M(+4.1%)
Mar 2017
-
$1.12 M(-0.9%)
$6.59 M(+0.4%)
Dec 2016
-
$1.13 M(-65.0%)
$6.57 M(-25.5%)
Sep 2016
$8.33 M(+72.3%)
$3.22 M(+183.5%)
$8.81 M(-0.0%)
Jun 2016
-
$1.13 M(+4.1%)
$8.81 M(+5.0%)
Mar 2016
-
$1.09 M(-67.7%)
$8.39 M(+8.2%)
Dec 2015
-
$3.37 M(+4.6%)
$7.75 M(+60.3%)
Sep 2015
$4.84 M
$3.22 M(+351.3%)
$4.84 M(+153.0%)
Jun 2015
-
$713.50 K(+58.1%)
$1.91 M(-1.1%)
Mar 2015
-
$451.20 K(-0.2%)
$1.93 M(-18.9%)
DateAnnualQuarterlyTTM
Dec 2014
-
$452.10 K(+53.1%)
$2.38 M(+6.6%)
Sep 2014
$2.24 M(+19.4%)
$295.30 K(-59.8%)
$2.24 M(-32.5%)
Jun 2014
-
$733.80 K(-18.7%)
$3.31 M(+24.3%)
Mar 2014
-
$903.00 K(+196.6%)
$2.67 M(+41.1%)
Dec 2013
-
$304.40 K(-77.8%)
$1.89 M(+0.9%)
Sep 2013
$1.87 M(+12.9%)
$1.37 M(+1476.0%)
$1.87 M(+81.9%)
Jun 2013
-
$87.00 K(-31.3%)
$1.03 M(-17.3%)
Mar 2013
-
$126.60 K(-56.0%)
$1.24 M(-16.1%)
Dec 2012
-
$287.90 K(-45.5%)
$1.48 M(-10.9%)
Sep 2012
$1.66 M(-53.5%)
$528.00 K(+74.9%)
$1.66 M(-5.9%)
Jun 2012
-
$301.90 K(-17.2%)
$1.77 M(-23.9%)
Mar 2012
-
$364.60 K(-22.2%)
$2.32 M(-26.8%)
Dec 2011
-
$468.50 K(-25.9%)
$3.17 M(-11.2%)
Sep 2011
$3.57 M(+22.7%)
$632.20 K(-26.2%)
$3.57 M(-6.3%)
Jun 2011
-
$856.10 K(-29.6%)
$3.81 M(+4.6%)
Mar 2011
-
$1.22 M(+39.8%)
$3.65 M(+16.4%)
Dec 2010
-
$869.30 K(-0.4%)
$3.13 M(+6.9%)
Sep 2010
$2.91 M(+12.3%)
$872.60 K(+26.8%)
$2.93 M(+5.1%)
Jun 2010
-
$688.10 K(-1.9%)
$2.79 M(-3.9%)
Mar 2010
-
$701.70 K(+5.0%)
$2.90 M(+9.9%)
Dec 2009
-
$668.30 K(-8.4%)
$2.64 M(+1.8%)
Sep 2009
$2.59 M(-31.6%)
$729.90 K(-8.9%)
$2.59 M(-25.1%)
Jun 2009
-
$801.20 K(+81.6%)
$3.46 M(-7.6%)
Mar 2009
-
$441.10 K(-29.0%)
$3.75 M(+0.1%)
Dec 2008
-
$621.70 K(-61.1%)
$3.74 M(-1.9%)
Sep 2008
$3.79 M(+513.1%)
$1.60 M(+47.4%)
$3.81 M(+54.9%)
Jun 2008
-
$1.09 M(+149.0%)
$2.46 M(+54.8%)
Mar 2008
-
$436.10 K(-37.0%)
$1.59 M(+22.6%)
Dec 2007
-
$692.30 K(+178.3%)
$1.30 M(+110.0%)
Sep 2007
$618.20 K(+2324.3%)
$248.80 K(+16.3%)
$618.20 K(+64.8%)
Jun 2007
-
$214.00 K(+49.4%)
$375.10 K(+124.9%)
Mar 2007
-
$143.20 K(+1073.8%)
$166.80 K(+489.4%)
Dec 2006
-
$12.20 K(+114.0%)
$28.30 K(+11.0%)
Sep 2006
$25.50 K(-72.1%)
$5700.00(0.0%)
$25.50 K(+28.8%)
Jun 2006
-
$5700.00(+21.3%)
$19.80 K(+40.4%)
Mar 2006
-
$4700.00(-50.0%)
$14.10 K(+50.0%)
Dec 2005
-
$9400.00(>+9900.0%)
$9400.00(>+9900.0%)
Sep 2005
$91.50 K(>+9900.0%)
-
-
Dec 2004
-
$0.00
$0.00
Sep 2004
$0.00
-
-

FAQ

  • What is Anavex Life Sciences annual SGA?
  • What is the all time high annual SGA for Anavex Life Sciences?
  • What is Anavex Life Sciences annual SGA year-on-year change?
  • What is Anavex Life Sciences quarterly SGA?
  • What is the all time high quarterly SGA for Anavex Life Sciences?
  • What is Anavex Life Sciences quarterly SGA year-on-year change?
  • What is Anavex Life Sciences TTM SGA?
  • What is the all time high TTM SGA for Anavex Life Sciences?
  • What is Anavex Life Sciences TTM SGA year-on-year change?

What is Anavex Life Sciences annual SGA?

The current annual SGA of AVXL is $11.04 M

What is the all time high annual SGA for Anavex Life Sciences?

Anavex Life Sciences all-time high annual SGA is $13.07 M

What is Anavex Life Sciences annual SGA year-on-year change?

Over the past year, AVXL annual SGA has changed by -$1.00 M (-8.31%)

What is Anavex Life Sciences quarterly SGA?

The current quarterly SGA of AVXL is $3.15 M

What is the all time high quarterly SGA for Anavex Life Sciences?

Anavex Life Sciences all-time high quarterly SGA is $3.90 M

What is Anavex Life Sciences quarterly SGA year-on-year change?

Over the past year, AVXL quarterly SGA has changed by +$365.00 K (+13.12%)

What is Anavex Life Sciences TTM SGA?

The current TTM SGA of AVXL is -$1.32 B

What is the all time high TTM SGA for Anavex Life Sciences?

Anavex Life Sciences all-time high TTM SGA is -$106.00 K

What is Anavex Life Sciences TTM SGA year-on-year change?

Over the past year, AVXL TTM SGA has changed by -$1.33 B (-11974.69%)